Sign Up to Receive the Latest Trading Tips and News from Prosper

    February 25, 2019

    Zosano On the Launching Pad Again

    Zosano Pharma Corp (ZSAN) shares were up over 23% today following news last week that the company reached its final milestone in its long-term safety study of Qtrypta for the acute treatment of migraine disease. The stock is still well below the 6.65 high price from February 21st, but we can now expect the stock […]

    Read Article
    February 21, 2019

    No More Headaches For Zosana Pharma?

    Zosano Pharma Corp (ZSAN) shares rose dramatically today due to the news that the company met the final milestones for its long-term safety study of Qtrypta, an acute treatment for migraine disease. The stock moved up over +180% on extremely high volume, with very little hesitation along the way. Here’s a recap.

    Read Article